miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W
- 8 April 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (9) , 6875-6882
Abstract
Increasing evidence has demonstrated that small non-coding microRNAs (miRNAs) play important roles in cancer development and progression. Recent studies have shown that microRNA-335 (miR-335) functions as an oncogene or a tumor suppressor in various human cancer types, but its role in clear cell renal cell carcinoma (ccRCC) remains poorly understood. In our study, we firstly found that the expression level of miR-335 was significantly downregulated in ccRCC tissues versus corresponding non-tumor tissues and the low expression of miR-335 was significantly associated with lymph node metastasis, larger tumor size, and poor T stage. Then, we found that overexpression of miR-335 significantly suppressed the proliferation and invasion of 786-O and CaKi-1 ccRCC cell lines. We subsequently found that miR-335 could interact with the 3′-untranslated regions (3′UTR) of B-cell CLL/lymphoma 2 like 2 (BCL-W or BCL2L2) messenger RNA (mRNA) and repress its expression. In addition, re-expression of BCL-W (without the 3′UTR) could partially abrogate the miR-335-induced 786-O and CaKi-1 ccRCC cell proliferation and invasion inhibition. Furthermore, we found that expression patterns of miR-335 were inversely correlated with those of BCL-W mRNA in ccRCC tissues. Taken together, these results indicate that miR-335 acts as a novel tumor suppressor to regulate ccRCC cell proliferation and invasion through downregulation of BCL-W expression.Keywords
This publication has 32 references indexed in Scilit:
- Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationshipsJournal of Cancer Research and Therapeutics, 2014
- miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomasJournal of Neuro-Oncology, 2012
- Identification of hsa-miR-335 as a Prognostic Signature in Gastric CancerPLOS ONE, 2012
- MicroRNA 335 Is Required for Differentiation of Malignant Glioma Cells Induced by Activation of cAMP/Protein Kinase A PathwayMolecular Pharmacology, 2012
- MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1Oncogene, 2011
- Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumorGynecologic Oncology, 2010
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- Role of microRNAs in drug-resistant ovarian cancer cellsGynecologic Oncology, 2008
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001